News related to the UNC Lineberger Comprehensive Cancer Center and the N.C. Cancer Hospital

Latest News from UNC Lineberger
Bladder cancer model could pave the way for better drug efficacy studies
In the journal Cancer Research, UNC Lineberger’s William Y. Kim, MD, Benjamin G. Vincent, MD, and colleagues report they have developed a mouse model of luminal bladder cancer, one of the two subtypes of advanced bladder cancer. The researchers said this model may help them to determine which patients may respond to immunotherapy treatments called checkpoint inhibitors.
Knowledge of e-cigarette health risk doesn't deter teen use, survey shows
UNC Lineberger's Seth Noar, PhD, and colleagues found that the majority of teenagers they surveyed knew about many of the health risks of e-cigarettes, but it had no influence on whether they had used e-cigarettes. However, they determined beliefs about addiction were a key discriminating factor among those who had and had not used e-cigarettes.
Roth, Johnson awarded $28 million for Illuminating Druggable Genome NIH grants
The grants are part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.
Damania earns Faculty Award for Excellence in Doctoral Mentoring
UNC Lineberger's Blossom Damania, PhD, vice dean for research at the UNC School of Medicine, was honored with the award at the UNC-Chapel Hill doctoral hooding ceremony May 12.
Could reading our circadian clocks according to DNA repair optimize chemotherapy?
For the first time, UNC Lineberger scientists led by Nobel laureate Aziz Sancar analyzed whole-genome DNA repair in an animal over 24 hours to find which genes were repaired, where exactly, and when, laying the groundwork for a more precise use of anti-cancer drugs.